{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:36:04Z","timestamp":1792427764644,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jaip.2021.02.013","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T12:15:58Z","timestamp":1613909758000},"page":"1851-1857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Innate and Adaptive Immunity: ILC2 and Th2 Cells in Upper and Lower Airway Allergic Diseases"],"prefix":"10.1016","volume":"9","author":[{"given":"Glenis K.","family":"Scadding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy W.","family":"Scadding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.02.013_bib1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.860134","article-title":"Evolution and tinkering","volume":"196","author":"Jacob","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.jaip.2021.02.013_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11882-020-00977-7","article-title":"Mechanisms of allergen immunotherapy in allergic rhinitis","volume":"21","author":"Drazdauskait\u0117","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2021.02.013_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.immunol.24.021605.090542","article-title":"The evolution of adaptive immunity","volume":"24","author":"Pancer","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jaip.2021.02.013_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2014a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri.2017.86","article-title":"Innate lymphoid cells: major players in inflammatory diseases","volume":"17","author":"Ebbo","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib8","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41467-017-02023-z","article-title":"Alternative activation generates IL-10 producing type 2 innate lymphoid cells","volume":"8","author":"Seehus","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2021.02.013_bib9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nm.2760","article-title":"T\u00a0cell homing to epithelial barriers in allergic disease","volume":"18","author":"Islam","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2021.02.013_bib10","first-page":"116","article-title":"Cytokine and lipid mediator regulation of group 2 innate lymphoid cells (ILC2s) in human allergic airway disease","volume":"2","author":"Cavagnero","year":"2017","journal-title":"J\u00a0Cytokine Biol"},{"key":"10.1016\/j.jaip.2021.02.013_bib11","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.jaci.2013.01.035","article-title":"Prostaglandin D(2) pathway upregulation: relation to asthma severity, control, and TH2 inflammation","volume":"131","author":"Fajt","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/mi.2013.92","article-title":"TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers","volume":"7","author":"Yu","year":"2014","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1164\/rccm.201410-1793OC","article-title":"PGI signaling inhibits group 2 innate lymphoid cell responses","volume":"193","author":"Zhou","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.02.013_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2021.02.013_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2013.05.012","article-title":"IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction","volume":"132","author":"Barlow","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaci.2016.03.044","article-title":"Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses","volume":"139","author":"De Grove","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib17","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.1003020","article-title":"The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses","volume":"186","author":"Kouzaki","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000356341","article-title":"Innate type 2 response to Alternaria extract enhances rye grass-induced lung inflammation","volume":"163","author":"Kim","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/eji.201142018","article-title":"Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma","volume":"42","author":"Klein","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2014.02.033","article-title":"Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures","volume":"133","author":"Gold","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib21","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1073\/pnas.1003059107","article-title":"IL-33 is a crucial amplifier of innate rather than acquired immunity","volume":"107","author":"Oboki","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2021.02.013_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2011.12.020","article-title":"Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation","volume":"36","author":"Halim","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2021.02.013_bib23","first-page":"302","article-title":"Occupational asthma after inhalation of dust of the proteolytic enzyme, papain","volume":"32","author":"Milne","year":"1975","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.jaip.2021.02.013_bib24","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1165\/rcmb.2010-0516OC","article-title":"Infection with influenza virus induces IL-33 in murine lungs","volume":"45","author":"Le Goffic","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2021.02.013_bib25","doi-asserted-by":"crossref","first-page":"e1003615","DOI":"10.1371\/journal.ppat.1003615","article-title":"Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection","volume":"9","author":"Gorski","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaip.2021.02.013_bib26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib27","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in\u00a0vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.02.013_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/WOX.0b013e31821188e0","article-title":"Interleukin-13 signaling and its role in asthma","volume":"4","author":"Rael","year":"2011","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2021.02.013_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cyto.2015.05.014","article-title":"IL-4 and IL-13 signaling in allergic airway disease","volume":"75","author":"Gour","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jaip.2021.02.013_bib30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/ni.2303","article-title":"The many lives of IL-9: a question of survival?","volume":"13","author":"Wilhelm","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.immuni.2015.01.020","article-title":"Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair","volume":"42","author":"Zaiss","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2021.02.013_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature23469","article-title":"Neuronal regulation of type 2 innate lymphoid cells via neuromedin U","volume":"549","author":"Cardoso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2021.02.013_bib33","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.aan4829","article-title":"b2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses","volume":"359","author":"Moriyama","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jaip.2021.02.013_bib34","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of Innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2021.02.013_bib35","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ni.3553","article-title":"Evidence of innate lymphoid cell redundancy in humans [published correction appears in Nat Immunol 2016;17:1479]","volume":"17","author":"V\u00e9ly","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2021.02.013_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cea.13775","article-title":"Repetitive nasal allergen challenge in allergic rhinitis: priming and Th2-type inflammation but no evidence of remodelling","volume":"51","author":"Orban","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.02.013_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41572-020-00227-0","article-title":"Allergic rhinitis","volume":"6","author":"Bousquet","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaip.2021.02.013_bib39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4168\/aair.2016.8.3.216","article-title":"Allergen-dependent differences in ILC2s frequencies in patients with allergic rhinitis","volume":"8","author":"Fan","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2021.02.013_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clim.2017.09.008","article-title":"Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis","volume":"183","author":"Zhong","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib41","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jaci.2014.07.029","article-title":"Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy","volume":"134","author":"Lao-Araya","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib42","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2013.12.1086","article-title":"Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84","volume":"133","author":"Doherty","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib43","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(58)91385-0","article-title":"Treatment of chronic asthma with prednisolone: significance of eosinophils in the sputum","volume":"2","author":"Brown","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.02.013_bib44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jaci.2008.10.022","article-title":"CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation","volume":"123","author":"Allakhverdi","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib45","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1165\/rcmb.2016-0099OC","article-title":"IL-13+ type 2 innate lymphoid cells correlate with asthma control status and treatment response","volume":"55","author":"Jia","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2021.02.013_bib46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","article-title":"Enhanced innate type 2 immune response in peripheral blood from patients with asthma","volume":"134","author":"Bartemes","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/all.14318","article-title":"Guttman-Yassky E, et al. Type 2 immunity in the skin and lungs","volume":"75","author":"Akdis","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.02.013_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/crj.12128","article-title":"Allergens, germs and asthma","volume":"9","author":"Scadding","year":"2015","journal-title":"Clin Respir J"},{"key":"10.1016\/j.jaip.2021.02.013_bib49","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","article-title":"A\u00a0large-scale, consortium-based genome wide association study of asthma","volume":"363","author":"Moffatt","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.02.013_bib50","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature06014","article-title":"Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma","volume":"448","author":"Moffatt","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2021.02.013_bib51","doi-asserted-by":"crossref","first-page":"1801809","DOI":"10.1183\/13993003.01809-2018","article-title":"Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids","volume":"54","author":"Nagakumar","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2021.02.013_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fped.2018.00258","article-title":"Classification of pediatric asthma: from phenotype discovery to clinical practice","volume":"6","author":"Oksel","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2021.02.013_bib53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.02.013_bib54","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1046\/j.1365-2222.2003.01737.x","article-title":"\u201cEntopy\u201d: localized mucosal allergic disease in the absence of systemic responses for atopy","volume":"33","author":"Powe","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.02.013_bib55","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jaci.2012.02.032","article-title":"Local allergic rhinitis: concept, pathophysiology, and management","volume":"129","author":"Rond\u00f3n","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib56","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1365-2222.2007.02838.x","article-title":"Local immunoglobulin production in nasal polyposis is modulated by superantigens","volume":"37","author":"Van Zele","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.02.013_bib57","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0167-5699(99)01535-2","article-title":"The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences","volume":"20","author":"Humbert","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaip.2021.02.013_bib58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1945892418807590","article-title":"Chronic rhinosinusitis\u2014could phenotyping or endotyping aid therapy?","volume":"33","author":"Muluk","year":"2019","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2021.02.013_bib59","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/all.12440","article-title":"Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis","volume":"69","author":"Miljkovic","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.02.013_bib60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clim.2014.09.007","article-title":"Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness","volume":"155","author":"Walford","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib61","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib62","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/ncomms3675","article-title":"Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation","volume":"4","author":"Kabata","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaip.2021.02.013_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2016.11.023","article-title":"Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease","volume":"140","author":"Eastman","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib64","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4168\/aair.2018.10.6.662","article-title":"Decreased CRTH2 expression and response to allergen re-stimulation on innate lymphoid cells in patients with allergen-specific immunotherapy","volume":"10","author":"Mitthamsiri","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"issue":"5","key":"10.1016\/j.jaip.2021.02.013_bib65","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11882-003-0082-x","article-title":"Immunotherapy in fungal allergy","volume":"3","author":"Helbling","year":"2003","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2021.02.013_bib66","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.02.013_bib67","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","article-title":"A\u00a0study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma","volume":"176","author":"Flood-Page","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.02.013_bib68","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2021.02.013_bib69","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jaci.2018.08.031","article-title":"Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: indirect treatment comparison","volume":"143","author":"Busse","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/TCRM.S192392","article-title":"Updated evaluation of dupilumab in the treatment of asthma: patient selection and reported outcomes","volume":"16","author":"Brooks","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jaip.2021.02.013_bib71","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.alit.2020.02.002","article-title":"Granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2021.02.013_bib72","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1710-1492-7-9","article-title":"Long-term benefits of omalizumab in a patient with severe non-allergic asthma","volume":"7","author":"Menzella","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib74","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12931-020-01505-x","article-title":"Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?","volume":"21","author":"Menzies-Gow","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2021.02.013_bib76","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/0091-6749(84)90361-0","article-title":"Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin","volume":"73","author":"Stevenson","year":"1984","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.02.013_bib77","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jaip.2019.03.044","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.02.013_bib78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.02.013_bib79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1939-4551-7-18","article-title":"Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease","volume":"7","author":"Howe","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2021.02.013_bib80","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2500\/aap.2019.40.4241","article-title":"Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease","volume":"40","author":"Jean","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2021.02.013_bib81","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s42256-020-00232-8","article-title":"Integration of mechanistic immunological knowledge into a machine learning pipeline improves predictions","volume":"2","author":"Culos","year":"2020","journal-title":"Nat Mach Intell"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821001938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821001938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:26:40Z","timestamp":1761974800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821001938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213219821001938"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.02.013","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate and Adaptive Immunity: ILC2 and Th2 Cells in Upper and Lower Airway Allergic Diseases","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}